BETing on rational combination therapy in mutant FLT3 acute myeloid leukemia

по Stone, Richard M.
Опубликовано в: Haematologica (2020)

Older adults with acute myeloid leukemia treated with intensive chemotherapy: “old” prognostic algorithms may not apply

по Stone, Richard M., Lindsley, Coleman
Опубликовано в: Haematologica (2018)

Novel therapy in Acute myeloid leukemia (AML): moving toward targeted approaches

по Winer, Eric S., Stone, Richard M.
Опубликовано в: Ther Adv Hematol (2019)

AKT1 induces caspase-mediated cleavage of the CDK inhibitor p27Kip1 during cell cycle progression in leukemia cells transformed by FLT3-ITD

по Yang, Xinping, Liu, Suiyang, Kharbanda, Surender, Stone, Richard M
Опубликовано 2011

Calcium pyrophosphate crystal inflammatory arthritis (pseudogout) with myelodysplastic syndrome: A new paraneoplastic syndrome?

по Tedeschi, Sara K., Stone, Richard M., Helfgott, Simon M.
Опубликовано в: J Rheumatol (2017)

Midostaurin: its odyssey from discovery to approval for treating acute myeloid leukemia and advanced systemic mastocytosis

по Stone, Richard M., Manley, Paul W., Larson, Richard A., Capdeville, Renaud
Опубликовано в: Blood Adv (2018)

Refractory myeloid sarcoma with a FIP1L1-PDGFRA rearrangement detected by clinical high throughput somatic sequencing

по Mandelker, Diana, Dal Cin, Paola, Jacene, Heather A., Armand, Philippe, Stone, Richard M., Lindeman, Neal I.
Опубликовано в: Exp Hematol Oncol (2015)

Discovery of a Highly Potent and Selective Indenoindolone Type 1 Pan-FLT3 Inhibitor

по Hatcher, John M., Weisberg, Ellen, Sim, Taebo, Stone, Richard M., Liu, Suiyang, Griffin, James D., Gray, Nathanael S.
Опубликовано в: ACS Med Chem Lett (2016)

Rate of differentiation syndrome in patients based on timing of initial all-trans retinoic acid administration

по Nauffal, Mary, Werner, Lillian, Ni, Jian, Stone, Richard M., DeAngelo, Daniel J., McDonnell, Anne M.
Опубликовано в: Leuk Res Rep (2019)

Application of multi-state models in cancer clinical trials

по Le-Rademacher, Jennifer G, Peterson, Ryan A, Therneau, Terry M, Sanford, Ben L, Stone, Richard M, Mandrekar, Sumithra J
Опубликовано в: Clin Trials (2018)

SYK Regulates mTOR Signaling in AML

по Carnevale, Julia, Ross, Linda, Puissant, Alexandre, Banerji, Versha, Stone, Richard M., DeAngelo, Daniel J., Ross, Kenneth N., Stegmaier, Kimberly
Опубликовано 2013

Evaluation of event-free survival as a robust end point in untreated acute myeloid leukemia (Alliance A151614)

по Yin, Jun, LaPlant, Betsy, Uy, Geoffrey L., Marcucci, Guido, Blum, William, Larson, Richard A., Stone, Richard M., Mandrekar, Sumithra J.
Опубликовано в: Blood Adv (2019)

Prevalence of Cognitive Impairment and Association With Survival Among Older Patients With Hematologic Cancers

по Hshieh, Tammy T., Jung, Wooram F., Grande, Laura J., Chen, Jiaying, Stone, Richard M., Soiffer, Robert J., Driver, Jane A., Abel, Gregory A.
Опубликовано в: JAMA Oncol (2018)

Oncology an evidence-based approach /

по Chang, Alfred E., Ganz, Patricia A., Hayes, Daniel F., Kinsella, Timothy., Pass, Harvey I., Schiller, Joan H., Stone, Richard M., Strecher, Victor.
Опубликовано 2006.

Relationship between obesity and clinical outcome in adults with acute myeloid leukemia: A pooled analysis from four CALGB (Alliance) clinical trials

по Castillo, Jorge J., Mulkey, Flora, Geyer, Susan, Kolitz, Jonathan E., Blum, William, Powell, Bayard L., George, Stephen L., Larson, Richard A., Stone, Richard M.
Опубликовано в: Am J Hematol (2015)

Identification of ILK as a novel therapeutic target for acute and chronic myeloid leukemia

по de la Puente, Pilar, Weisberg, Ellen, Muz, Barbara, Nonami, Atsushi, Luderer, Micah, Stone, Richard M., Melo, Junia V., Griffin, James D., Azab, Abdel Kareem
Опубликовано в: Leuk Res (2015)

Acute myeloid leukemia cells require 6-phosphogluconate dehydrogenase for cell growth and NADPH-dependent metabolic reprogramming

по Bhanot, Haymanti, Weisberg, Ellen L., Reddy, Mamatha M., Nonami, Atsushi, Neuberg, Donna, Stone, Richard M., Podar, Klaus, Salgia, Ravi, Griffin, James D., Sattler, Martin
Опубликовано в: Oncotarget (2017)

Geriatric Assessment in Older Patients with Acute Myeloid Leukemia: A Retrospective Study of Associated Treatment and Outcomes

по Sherman, Alexander E., Motyckova, Gabriela, Fega, K. Rebecca, DeAngelo, Daniel J., Abel, Gregory A., Steensma, David, Wadleigh, Martha, Stone, Richard M., Driver, Jane A.
Опубликовано 2013

Feasibility of administering oblimersen (G3139; Genasense) with imatinib mesylate in patients with imatinib resistant chronic myeloid leukemia – Cancer and leukemia group B study 1...

по WETZLER, MEIR, DONOHUE, KATHLEEN A., ODENIKE, OLATOYOSI M., FELDMAN, ERIC J., HURD, DAVID D., STONE, RICHARD M., WESTERFELT, PETER, BLOOMFIELD, CLARA D., LARSON, RICHARD A.
Опубликовано 2008

A Phase II Study of the EGFR inhibitor gefitinib in patients with acute myeloid leukemia

по DeAngelo, Daniel J., Neuberg, Donna, Amrein, Philip C., Berchuck, Jacob, Wadleigh, Martha, Sirulnik, L. Andres, Galinsky, Ilene, Golub, Todd, Stegmaier, Kimberly, Stone, Richard M.
Опубликовано в: Leuk Res (2013)